These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 16002502
41. Hydrotherapy of patients with intermittent claudication: a novel approach to improve systolic ankle pressure and reduce symptoms. Elmståhl S, Lilja B, Bergqvist D, Brunkwall J. Int Angiol; 1995 Dec; 14(4):389-94. PubMed ID: 8708433 [Abstract] [Full Text] [Related]
42. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction. Wang Z, Chen K, Gong J, Zheng Y, Wang T. Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831 [Abstract] [Full Text] [Related]
43. Twelve-month results of percutaneous endovascular reconstruction for chronically occluded superficial femoral arteries: a quality-of-life assessment. Dippel E, Shammas N, Takes V, Coyne L, Lemke J. J Invasive Cardiol; 2006 Jul; 18(7):316-21. PubMed ID: 16816437 [Abstract] [Full Text] [Related]
48. Risk attitudes to treatment among patients with severe intermittent claudication. Letterstål A, Forsberg C, Olofsson P, Wahlberg E. J Vasc Surg; 2008 May; 47(5):988-94. PubMed ID: 18455642 [Abstract] [Full Text] [Related]
49. The relationship of walking distances estimated by the patient, on the corridor and on a treadmill, and the Walking Impairment Questionnaire in intermittent claudication. Frans FA, Zagers MB, Jens S, Bipat S, Reekers JA, Koelemay MJ. J Vasc Surg; 2013 Mar; 57(3):720-727.e1. PubMed ID: 23313183 [Abstract] [Full Text] [Related]
50. Supervised exercise training for intermittent claudication: lasting benefit at three years. Ratliff DA, Puttick M, Libertiny G, Hicks RC, Earby LE, Richards T. Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):322-6. PubMed ID: 17587612 [Abstract] [Full Text] [Related]
51. Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Ouzouni S, Kouidi E, Sioulis A, Grekas D, Deligiannis A. Clin Rehabil; 2009 Jan; 23(1):53-63. PubMed ID: 19114437 [Abstract] [Full Text] [Related]
52. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Treat-Jacobson D, Bronas UG, Leon AS. Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669 [Abstract] [Full Text] [Related]
53. Self-reported estimation of usual walking speed improves the performance of questionnaires estimating walking capacity in patients with vascular-type claudication. Mahe G, Ouedraogo N, Marchand J, Vielle B, Picquet J, Leftheriotis G, Abraham P. J Vasc Surg; 2011 Nov; 54(5):1360-5. PubMed ID: 22027439 [Abstract] [Full Text] [Related]
54. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenburg NC, Thum CC, Goldberg S, Jaff MR, Steffes MW, Comerota AJ, Ehrman J, Treat-Jacobson D, Walsh ME, Collins T, Badenhop DT, Bronas U, Hirsch AT, CLEVER Study Investigators. Circulation; 2012 Jan 03; 125(1):130-9. PubMed ID: 22090168 [Abstract] [Full Text] [Related]
55. Outcome of conservative therapy of patients with severe intermittent claudication. Amighi J, Sabeti S, Schlager O, Francesconi M, Ahmadi R, Minar E, Schillinger M. Eur J Vasc Endovasc Surg; 2004 Mar 03; 27(3):254-8. PubMed ID: 14760593 [Abstract] [Full Text] [Related]
56. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial. Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JA, Hoffmann WH, Smits TM, van Brussel JP, Stultiens GN, Derom A, den Hoed PT, Ho GH, van Dijk LC, Verhofstad N, Orsini M, van Petersen A, Woltman K, Hulst I, van Sambeek MR, Rizopoulos D, Rouwet EV, Hunink MG. JAMA; 2015 Nov 10; 314(18):1936-44. PubMed ID: 26547465 [Abstract] [Full Text] [Related]
57. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease. Brass EP, Anthony R, Cobb FR, Koda I, Jiao J, Hiatt WR. J Am Coll Cardiol; 2006 Dec 19; 48(12):2539-45. PubMed ID: 17174195 [Abstract] [Full Text] [Related]
58. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460. Kurklinsky AK, Levy M. Vasc Med; 2013 Aug 19; 18(4):234-6. PubMed ID: 23867841 [Abstract] [Full Text] [Related]
59. Impact of claudication and its treatment on quality of life. Spronk S, White JV, Bosch JL, Hunink MG. Semin Vasc Surg; 2007 Mar 19; 20(1):3-9. PubMed ID: 17386358 [Abstract] [Full Text] [Related]
60. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS). Tsuchida H, Shigematsu H, Ishimaru S, Iwai T, Akaba N, Umezu S. Int Angiol; 2006 Sep 19; 25(3):287-92. PubMed ID: 16878078 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]